Furthermore, mice harboring primary MPB1 tumors showed significantly improved survival following cisplatin therapy (Fig. 2E), a result that was recapitulated in mice following subcutaneous or intraperitoneal (i.p.)injection of primary EPO-GEMM tumor-derived cell lines (SI Appendix, Fig. S2 F–H). The gene discussed is EPO; the disease is neoplasm.